MedTrace Logo

Adaptive Interventions for Prevention/Intervention for Youth Substance Abuse

NCT03928756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2019-10-23

No results posted yet for this study

Summary

The main aim of this formative study is to test and iteratively refine a new mobile phone app, which delivers assessments and tailored intervention content. The study will use social media advertisements to recruit a total of 40 youth between the ages of 16-24 years. Those screening positive for past-month binge drinking or marijuana use will be invited to complete a baseline survey, download and use the app for 30 days, and complete a follow-up survey about the app functionality, design and content, and preliminary outcomes (intentions and importance of reducing use).

Conditions

  • Substance Use

Interventions

BEHAVIORAL

Push Notifications with Tailored Intervention Content

Participants will receive a push notification with a therapeutic message (e.g., about stress, mood, substance use motives, tools to reduce risky substance use) tailored to their recent daily or weekly survey responses. Messages include visual (memes, images, videos) and written content.

BEHAVIORAL

Push Notifications with Engaging, Non-therapeutic Content

Participants will receive a push notification with an engaging, non-therapeutic message (e.g., fun facts).

BEHAVIORAL

No Push Notifications

Participants will not receive a push notification.

Sponsors & Collaborators

Principal Investigators

  • Maureen Walton, MPH, PHD · University of Michigan

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2019-10-17
Completion
2019-10-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03928756 on ClinicalTrials.gov